Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial.
Sepede G, De Berardis D, Gambi F, Campanella D, La Rovere R, D'Amico M, Cicconetti A, Penna L, Peca S, Carano A, Mancini E, Salerno RM, Ferro FM.
Sepede G, et al.
J Clin Psychopharmacol. 2006 Feb;26(1):45-9. doi: 10.1097/01.jcp.0000195108.01898.17.
J Clin Psychopharmacol. 2006.
PMID: 16415705
Clinical Trial.